Terumo Overview
- Founded
-
1921
- Status
-
Public
- Employees
-
28,294
- Stock Symbol
-
4543
- Investments
-
24
- Share Price
-
$34.81
- (As of Monday Closing)
Terumo General Information
Description
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.
Contact Information
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Stock Exchange
TKS
Primary Office
- 2-44-1 Hatagaya
- Shibuya-ku
- Tokyo, 151-0072
- Japan
+81 00-0000-0000
Terumo Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $34.81 | $33.90 | $28.16 - $49.95 | $25.6B | 756M | 1.95M | $0.94 |
Terumo Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 22,805,743 | 23,468,696 | 28,098,678 | 26,432,136 |
| Revenue | 6,211,109 | 6,260,305 | 5,788,805 | 5,783,892 |
| EBITDA | 1,466,422 | 1,560,236 | 1,429,675 | 1,494,714 |
| Net Income | 709,928 | 790,550 | 728,672 | 783,676 |
| Total Assets | 11,592,060 | 12,074,704 | 12,248,420 | 11,486,258 |
| Total Debt | 1,724,125 | 1,851,698 | 2,362,032 | 2,278,033 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Terumo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Terumo Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management,
Medical Supplies
Tokyo, Japan
28,294
As of 2022
00000000
00000
adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000000 00000000
Osaka, Japan
00000
As of 0000
00000000
0000
it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000 000000000
Ballerup, Denmark
0000
As of 0000
0000
Add Comparison
Terumo Competitors (23)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nipro | Corporation | Osaka, Japan | 00000 | 00000000 | ||
| 0000 | Pending Transaction (M&A) | Ballerup, Denmark | 0000 | 0000 | ||
| 0ö0000000 000000 0 | Private Equity-Backed | Gothenburg, Sweden | 0000 | 00000 | 0000000 0000 | 00000 |
| 000000000 | Corporation | Mountain Ash, United Kingdom | 000 | |||
| 00000 00000000 | Private Equity-Backed | Caledonia, MI | 0000 | 00000 | 000000000000 | 00000 |
Terumo Patents
Terumo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-202022100987-U1 | Medical solution dispenser | Active | 25-Mar-2021 | 00000000000 | 0 |
| DE-202022100988-U1 | Dosing device for medical solutions | Active | 08-Mar-2021 | 000000000 | 0 |
| US-20220111183-A1 | Pulmonary embolism removal system | Pending | 12-Oct-2020 | 000000000 | |
| US-20220096011-A1 | Self-retaining device | Pending | 29-Sep-2020 | 00000000000 | |
| JP-2022055880-A | Detention device | Pending | 29-Sep-2020 | A61M5/14248 |
Terumo Executive Team (20)
Terumo Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Keiya Ozawa | Terumo | Board Member | 000 0000 |
| Kyo Nishikawa | Terumo | Board Member & Executive | 000 0000 |
| Ryuzo Ueda | Terumo | Director | 000 0000 |
| Shinjiro Sato | Terumo | Chief Executive Officer & Board Member | 000 0000 |
| Shoji Hatano | Terumo | Board Member & Executive | 000 0000 |
Terumo Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Terumo Investments & Acquisitions (24)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 05-Jul-2022 | 00000 0000 | 00000 | Therapeutic Devices | |
| 000000000 | 02-Jun-2022 | 00000 0000 | 0000 | Therapeutic Devices | 000000 00 |
| 000000 000000 | 24-Feb-2021 | 0000000000 | Decision/Risk Analysis | 00000 000 | |
| 0000000 00000 | 11-Aug-2020 | 0000000000 | Monitoring Equipment | ||
| Quirem Medical | 15-Jul-2020 | Merger/Acquisition | 0000 | Monitoring Equipment |
Terumo Subsidiaries (9)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Aortica | Other Devices and Supplies | Bellevue, WA | 2014 |
| 000000 0000000 | Monitoring Equipment | Deventer, Netherlands | 0000 |
| 000000 00000 | China | 0000 | |
| 0000000 0000000 | Monitoring Equipment | San Francisco, CA | 0000 |
| 0000000 0000000 | Other Devices and Supplies | Aliso Viejo, CA | 0000 |
Terumo Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 | 000000000000000000 | Completed |
|